Researchers have confirmed that urinary ethyl glucuronide (uEtG) tests are able to accurately detect alcohol consumption in liver transplant candidates and recipients.
The study published in Liver Transplantation, suggests that a combination of uEtG and the Alcohol Use Disorders Identification Test for alcohol consumption (AUDIT-c) are best in alerting doctors to alcohol consumption by patients undergoing evaluation for liver transplantation or who have received liver transplants. “Assessing alcohol consumption is crucial in the selection of liver transplant candidates,” said Dr. Paolo Angeli from the University of Padova in Italy. “Equally important is the ability to detect alcohol use in liver transplant recipients so early intervention for alcohol relapse can take place.”
